Skip to content

Regulating Rheumatoid Arthritis

Regulating Rheumatoid Arthritis - Regulating RA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON52768
Enrollment
145
Registered
2021-12-21
Start date
2023-03-23
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • Age range: >18 years • Diagnosed with Rheumatoid arthritis • Use of one or several small molecule anti-rheumatic drugs. Combination with biologicals is allowed. • Blood from healthy controls is obtained via the *mini-donor dienst* of the UMC Utrecht or purchased as buffy coats from Sanquin, and is anonymous, except for the age and sex

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Novel insights into various aspects of faulty immune regulation in RA, as well as the prerequisites for the development, implementation, and immunological monitoring of immune regulation restoring therapies in RA patients.

Countries

Netherlands

Contacts

Public ContactJ.M. van Laar

Universitair Medisch Centrum Utrecht

j.m.vanlaar@umcutrecht.nl0887557357

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)